The Initiative for Multipurpose Prevention Technologies (IMPT) develops tools and resources to inform MPT product development and investment decisions and to educate other interested stakeholders. .
|
Toward a Roadmap for Biomedical HIV Prevention Investment Standards: Strategic Insights from Key Industry Stakeholders | |
|
The United States Agency for International Development (USAID) is a major funder of biomedical HIV prevention product development. In response to USAID’s desire for standards to help guide decisions for prioritizing investments and integrating user perspectives at various stages of product development, the Initiative for MPTs (IMPT) provided technical assistance to USAID’s Office of HIV/AIDS (OHA) to develop a Biomedical HIV Prevention Product Investment Framework.
|
|
|
Market Access Framework for MPT Development | |
|
This framework is intended to serve as a resource to inform product development and investment decision-making that is focused specifically on market access components of MPT development and introduction—in other words, activities that are critical to ensuring that MPTs in development are not only efficacious in clinical trials, but also desired, acceptable, and accessible to women and adolescent girls once introduced and commercially available.
|
|
|
Market Access Framework for Multipurpose Prevention Technology (MPT) Development and Introducion | |
|
Dellplain, L., Young Holt, B., Hemmerling, A., Romano, J., van der Straten, A., & Turpin, J. (2016, January 21). Initiative for Multipurpose Prevention Technologies.
|
|
|
Traditional Socio-Behavioral Research and Human-Centered Design: Similarities, Unique Contributions and Synergies | |
|
This report by Dr. Betsy Tolley (FHI 360) presents learnings and reflections on traditional socio-behavioral research (SBR) and human-centered design (HCD) as applied to the global health context – specifically in biomedical prevention for sexual and reproductive health. In comparing these methodologies and examining their strengths and shortcomings, we can identify potential synergies to further inform the development and eventual introduction of MPTs in targeted end-user populations.
|
|
|
Join the MPT development collaboration | |
|
Whether your experience is in SRH prevention, drug delivery, novel formulation science, engineering, or polymer chemistry, the IMPT encourages a global collaboration among organizations who have paved the way for promising first-generation MPT products.
|
|
